leisure time -WSS

leisure time

author：entertainment 2025-09-03 07:46:55 - browse：759

Akero Therapeutics said Tuesday that an experimental medicine failed to show a significant benefit for patients with cirrhosis caused by NASH, the most advanced and life-threatening stage of the fatty liver disease.

While the study’s primary goal of improving liver fibrosis, or scarring, was not achieved, the Akero drug, called efruxifermin, outperformed placebo by 10 percentage points. The drug also resolved NASH symptoms, including reductions in liver fat and inflammation, and improved other markers of the disease.

“These are the best data reported to date for any NASH drug in this patient population,” said Kitty Yale, Akero’s chief development officer. “We missed the primary endpoint. We understand that, but there’s actually a lot of hope when you look at the totality of the data.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： 5 to watch: Tech startups trying to solve health care's staffing crisis

focus

WSS

App could help diagnose ear infections more accurately — and at home

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

AstraZeneca to buy developer of next

New company forms to vet health AI models, root out weaknesses

SCOTUS questions limit to govt efforts to fight misinformation

hotspot

leisure time

focus

After affirmative action ruling, medical educators look to 'holistic review'

California Joshua trees severely burned in massive wildfire

Wildfire smoke exposes gaps in outdoor worker protections

Stop the failed accountable care organization experiment

How one medical school became remarkably diverse

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Peter Hotez and the public health issue of online harassment

Lifetime voting ban for felony convictions struck down in Mississippi

Walensky prepares to leave CDC — and Congress — behind

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

knowledge

California Joshua trees severely burned in massive wildfire

CVS Caremark has created a new ploy: the drug ‘rebate credit’

5 to watch: Tech startups trying to solve health care's staffing crisis

Creating egg and sperm cells from stem cells raises ethical issues

California Joshua trees severely burned in massive wildfire

5 to watch: Tech startups trying to solve health care's staffing crisis

explore

explore

focus

focus